TD Cowen Remains Bullish on Intercontinental Exchange (ICE)
TD Cowen has reiterated a Buy rating on Intercontinental Exchange (ICE), despite cutting its price target to $153 from $193 due to concerns about perpetual futures impacting stock multiples. The firm notes that ICE's May 2026 statistics show strong performance, with average daily volume up 14% year-over-year and open interest up 24% year-over-year. While acknowledging ICE's potential, the article also suggests that certain AI stocks might offer greater returns in a shorter timeframe.
Constellation Energy (CEG) and Walmart Announce Long-Term Nuclear Power Purchase Agreement
Constellation Energy (CEG) and Walmart have signed a long-term agreement for emissions-free nuclear power from Constellation's Dresden Clean Energy Center in Illinois. This deal, involving 176 MW of wholesale supply and 30 MW of expanded capacity, facilitates Walmart's access to cleaner energy and supports local energy infrastructure, starting with two 15-year terms in 2029 and 2030. The new power will specifically support Walmart's upcoming high-tech perishable distribution center in Belvidere, Illinois.
Price to earnings forward of Waste Management, Inc. (CAD Hedged) – TSX:WAST
This article provides financial information for Waste Management, Inc. (CAD Hedged) listed on the Toronto Stock Exchange under the ticker WAST. It specifically focuses on the "Price to earnings forward" metric for the company. The page appears to be a financial data portal, offering various tools and community features.
Enterprise value to revenue forward of rYojbaba Co., Ltd. – NASDAQ:RYOJ
This article presents information about the enterprise value to revenue forward for rYojbaba Co., Ltd. (NASDAQ: RYOJ). It is an overview from TradingView, specifically focusing on the financial aspects of the company within the Medical/Nursing Services sector. The content reiterates the company's NASDAQ listing and indicates the market was closed at the time of publication, with no trades.
Recover Investment Losses: Class Action Initiated Against DexCom, Inc. (DXCM)
Levi & Korsinsky, LLP has initiated a securities class action lawsuit against DexCom, Inc. (DXCM) on behalf of investors who suffered losses between January 8, 2024, and September 17, 2025. The lawsuit alleges that DexCom made unauthorized design changes to its G6 and G7 glucose monitoring products, rendering them less reliable and presenting health risks, and that the company made false and misleading public statements. Investors who purchased DexCom securities during this period are encouraged to learn about their rights to potentially recover losses.
Price to book forward of Tyler Technologies, Inc. – GETTEX:TYP
This article displays the "Price to book forward" for Tyler Technologies, Inc. (GETTEX:TYP). The content primarily consists of a financial data display from TradingView, indicating market status, and providing disclaimers about data sources. No specific values for the metric are shown, only the structure where it would be presented.
Rosen Law Firm Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation - PFSI
The Rosen Law Firm is investigating potential securities claims against PennyMac Financial Services, Inc. (PFSI) after allegations of misleading business information. This investigation follows a significant drop in PennyMac's stock price after the company reported a substantial decline in its servicing segment pretax income for Q4 2025. Investors who purchased PennyMac securities are encouraged to contact the firm to join a prospective class action to recover losses.
Enterprise value to EBITDA forward of Proto Labs, Inc. – SWB:PRZ
The article focuses on the enterprise value to EBITDA forward metric for Proto Labs, Inc. (SWB:PRZ), traded on the Stuttgart Stock Exchange. It appears to be a financial data snippet or a specific page from a financial tracking platform like TradingView, providing an overview of the company's financial data. The content highlights the period, value, and change of this specific financial metric.
Synopsys Stock: Q2 Beat, Full-Year Raise, and an Elliott Catalyst the Street Calls Conservative
Synopsys (SNPS) reported a strong Q2 2026, beating revenue and EPS estimates and raising full-year guidance, driven by increasing semiconductor demand from AI and accelerated cost synergies from the Ansys acquisition. Analysts maintain a "buy" rating, with a mean price target suggesting 24% upside, and anticipate significant EBITDA margin expansion into 2027. Elliott Investment Management's involvement is seen as a key catalyst, pushing for faster synergy realization and stricter cost discipline, which analysts believe the market is not fully pricing in.
Enterprise value to EBITDA forward of Radcom Ltd. – NASDAQ:RDCM
This article displays the forward Enterprise Value to EBITDA for Radcom Ltd. (NASDAQ: RDCM). The content is primarily a data display from TradingView, indicating financial metrics for the company. It serves as a brief financial snapshot for potential investors or analysts.




